DSM-265

N/A

Report date: 2026/05/13 20:02:10
NME

Base Information

Drug NameDSM-265
Drug Alias NamePfSPZDSM-265
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydroorotate dehydrogenase inhibitors
TargetsDihydroorotate dehydrogenase
Therapy Area/IndicationsAcquired Immunodeficiency SyndromeMalaria, VivaxMalaria, Falciparum +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaGermany +[6] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co LtdMedicines for Malaria Venture
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Maryland, Baltimore
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Medicines for Malaria Venture
Active IndicationsMalaria
Inactive IndicationsAcquired Immunodeficiency SyndromeMalaria, VivaxMalaria, Falciparum

Other Information

ATC CodeN/A
Related LinksN/A